“This study further validates the potential of TriNav using the PEDD approach to transform the treatment of liver tumors,” said Bryan F. Cox, Ph.D., Chief of Research for ...
DENVER--(BUSINESS WIRE)-- TriSalus Life Sciences (TLSI) ®, Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), TriSalus Life Sciences seeks to transform outcomes for patients with solid tumors by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results